Across TCGA pan-cancer cohorts, OR10J3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR10J3’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR10J3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR10J3 is over-expressed in tumor.

BRCA and KIRC are the cancer types where OR10J3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR10J3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+0.011	.039	2	view →
KIRC	All	All	+0.011	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR10J3 RNA expression & survival · all OR10J3 data types